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Dat last follow-up showed a trend (P¼ .06) toward improved
survival compared with patients in AF. In matched patients,
successful treatment predicted survival, even after 1 year.
Because several prior studies have indicated reduced sur-
vival in patients with a history of AF, these results are en-
couraging and merit further investigation. This may have
implications for a broader application of AF surgery in
low-risk patients.References
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Dr John Doty (Murray, Utah). This study emphasizes the im-
portance of concomitant treatment of AF, particularly your last
graphs. Your follow-up is relatively short, but we may see that
those patients have improved survival by treatment of AF. There
is ongoing debate about the wide range of operations that are
used for the treatment of AF. Would you describe the particular
procedures your group uses for treatment of AF and how you de-
cide which patient gets what procedure in this complex group?
Dr Lee. I have another article that I am putting together that
looks at AF by lesion set, and in general our results are approxi-
mately 75% to 90% depending on the type of procedure that we
use in the patient population. Our rule of thumb is essentially
this. The American College of Cardiology/American Heart Asso-
ciation recommends treating everybody with AF if it does not add
anything more to the procedure. So if you are performing mitral
valve surgery, you are fairly obligated to do a full left-sided
Maze and strongly consider a right side, especially as more data
emerge that doing both by atrial lesion sets may improve AF out-
comes. On the flip side, if you have an elderly person undergoing
CABG, especially off-pump, and you are not going to open the
heart, well, it may be reasonable to do pulmonary vein isolationgery c June 2012
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Dalone. We segment it by procedure and by how AF affects the pa-
tient. If AF is a real problem, we make every effort to treat it with
the biatrial lesion set. If it is paroxysmal, especially if we are not
going to open the heart anyway, wewould do a more limited lesion
set like a PVI alone. And for those patients in between those ex-
tremes, we perhaps do a left-sided only Maze.
Dr Doty.Maybe you could clarify a bit more. When you say le-
sion sets, what energy modality are you using? You did mention in
your article sometimes you have cut and sew as an option.
Dr Lee. In the article you wrote 2 years ago, you showed that
cut and sew is probably better than everything else, and even
though some of the other reports conflict with that, we have a sim-
ilar experience. Now if you have a patient with AF and that is the
number 1 problem, you are going to do a cut-and-sewMaze. If you
have a patient who has paroxysmal or perhaps long-standing per-
sistent and not permanent AF, you will perform bipolar RF. The
majority of our patients are older, more frail, and so approximately
75% of our patients receive bipolar radiofrequency with supple-
mentation at the annulus with cryothermia.
Dr Doty.We all recognize that some surgeons may not be will-
ing to add an additional procedure for AF to what they are doing,
particularly if it is complex. Can you estimate for us howmuch ad-
ditional time it takes your group to do some type of ablative or inci-
sional Maze procedure?
Dr Lee. That is important, but even the experience of our group
is not as important as the experience of the whole population.
Gammie and colleagues wrote an article using the Society of Tho-
racic Surgeons’ database. In that added meta-analysis, they
showed that it added 9minutes to crossclamp time and 9 additional
minutes to bypass time in general. With the bypass time, you are
clamping the beating heart anyway. I think it is even less than
that in many instances, so if we are using bipolar radiofrequency
we go on pump. We do the pulmonary vein isolations on pump.
We stop the heart. We do the connecting lesions, and that really
does not take more than 1 minute of clamp time. Then we unclamp
and do the right-sided lesions if we are going to do it, and again
even if you do multiple lesions it is 40 seconds per burn times 3.
It is just a couple minutes per lesion, so in all it adds approximately
18 minutes at the most, but in general, more like 10 minutes for us.
Dr Doty. Your group is similar to ours. We have a strong bias to
treat everyone who presents with AF with some type of procedure
during their concomitant operation. I am particularly interested in
the subset of patients who had existing AF but did not receive
a concomitant procedure. You noted these patients were more ill
and had more comorbidities. If that is the case, shouldn’t these pa-
tients be the very ones who receive a concomitant operation, and, if
not, can you explain which patients in whom you would not per-
form an AF operation?The Journal of Thoracic and CarDr Lee. I did not analyze those data, but you know we have
shifted. Now we look at how many patients we have with AF,
and now we are at 90% of patients treated for AF, so we have
had a paradigm shift. We have a group we assembled right around
the beginning of that time period, and as we have gone on we have
increased the application, but we also use alternate energy sources,
so if you have a redo, for example, say a redo mitral that is pretty
stuck, you don‘t want to dissect out the whole heart. I don’t want to
do a cut-and-sew Maze in that patient. I don‘t even want to do bi-
polar radiofrequency in that patient because I don’t want to get
around the left-sided veins. But what we will do is use a CryoCath
(Medtronic Corporation, Minneapolis, Minn) around the entire
surface or Frigitronics cryo (Atricure Corporation, Cincinnati,
Ohio), 1 of those 2, and I would say we are down to not operating
on approximately 10% of the patients. In general, if we are not go-
ing to open the heart, say it is an 85-year-old patient with a redo
aortic valve, we are probably just going to do the redo aortic valve.
If it is a CABG, especially a redo, we probably would let that go if
it is an older or frail patient. That being said, now we are down to
approximately 10% or less of patients with a history of AF who are
in that category.
Dr Doty. Let me clarify. Are there specific patients in
whom you would not perform a concomitant operation? You
mentioned redos, if they are older. Are there other criteria you gen-
erally use?
Dr Lee. If the patient is older, we are not going to open the
heart. Even if the patient is old and a redo and we are going to per-
formmitral valve surgery, that is still easy to do a left sided, but the
guidelines state that it adds to the operation significantly, so I
would not open the heart in a 90-year-old patient with redo aortic
valves and patent grafts. That is clearly a patient I would not oper-
ate on. I cannot give you an individual patient because it is a case-
by-case decision, but that is clearly to the extreme where I say no.
Dr William Northrup (Atlanta, Ga). I wonder if the phrase
‘‘expected survival’’ is a little misleading. For instance, when we
say that mitral valve repair has the potential to restore expected
survival, we are comparing it with a normal matched population.
In this case, you are comparing 2 surgical subgroups. When I first
read the article, I thought this is pretty exciting. Nevertheless, the
article presents exciting data.
Dr Lee. Thank you for your comment, and wewill take that into
consideration for the final article. We did not compare with the
general population because we do not know what that survival
should be compared with regular cardiac surgery, but we do
know what survival should be for similar patients undergoing aor-
tic valve surgery, mitral valve surgery, and CABG, so by the word
‘‘expected,’’ that is what we meant, and we did restore it to that
population.diovascular Surgery c Volume 143, Number 6 1351
